Top

Neovasc Inc.

TSX Exchange | Apr 2, 2020, 2:31 AM EDT | Real-time price

NVCN $ 1.90 RT
CHANGE
-0.18 (-8.6538%)
VOLUME
15,294
Day Low: 1.90
Day High: 2.17
Detailed Quote
Open: 2.17
High: 2.17
Beta: 1.9495
Listed Shares Out.1: 11,133,319
Total Shares (All Classes)2: 11,133,369
Prev. Close: 2.08
Low: 1.90
VWAP: 2.0298
Market Cap1: 21,153,306
Market Cap (All Classes)2*: 21,153,401
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: 0.10
EPS: 27.87
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -1.712
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. Neovasc is developing the Tiara for the treatment of mitral valve disease. Neovasc operates its business in one segment. More

News Headlines for Neovasc Inc.
Research
News Headlines for Neovasc Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.